Acorda Therapeutics reported positive Phase 3 results demonstrating that CVT-301 improved motor function in people with Parkinson’s disease (PD) experiencing off periods. Such periods are times when background L-dopa therapy does not control Parkinson’s symptoms. About 50 percent of patients using L-dopa have off periods, which are very disruptive…
Parkinson’s disease patients now have two additional Centers of Excellence at their service: the NewYork-Presbyterian/Columbia University Medical Center in New York and the Rush University Medical Center in Chicago. The global network is run by the Parkinson’s Foundation, which supports initiatives of different types to help improve the…
Yoga has been shown to increase flexibility and posture, ease stiffness, and improve balance through the strengthening of core muscles in patients with Parkinson’s disease. Kaitlyn P. Roland, PhD, a yoga teacher at the Parkingo Wellness Society in Victoria, Canada, and a specialist in studies of the rehabilitative needs…
A hand-grip test is one of the best measures of muscle decline in Parkinson’s disease, research indicates. Two University of British Columbia researchers, Jenn Jakobi and Gareth Jones, researched methods used to monitor the progression of Parkinson’s. Their study, “Handgrip Strength Related to Long-Term Electromyography,” was published in the…
The first patient has been dosed in a two-part Phase 1 clinical trial evaluating KM-819, Kainos Medicine’s potential disease-modifying treatment for Parkinson’s disease (PD), the company announced in a press release. The dose-escalation clinical trial (NCT03022799) will evaluate the drug’s safety, tolerability, and biochemical properties following single…
It’s widely recognized that falling poses a significant risk for people with Parkinson’s disease (PD), but most scientists thought patients tended to fall in later stages of the disease. Researchers in Norway have found that 25 percent of Parkinson’s patients fell in the first year of their diagnosis. Parkinson’s disease…
MYOLYN has asked the U.S. Food and Drug Administration (FDA) for a patent for the functional electrical stimulation (FES) bikes it makes for people with neurological and muscle conditions such as Parkinson’s disease (PD). The FDA is already reviewing the company’s MyoCycle Home and MyoCycle Pro stationary…
The European Union Joint Programme — Neurodegenerative Disease Research (JPND) has launched a call for proposals for “multinational research projects for pathway analysis across neurodegenerative diseases,” such as Parkinson’s disease (PD). Neurodegenerative diseases are a health, social, and economic problem in Europe and across the globe. With this in…
Genervon Biopharmaceuticals has published a previously confidential list of Parkinson’s disease-associated (PD) genes it says are controlled by GM6, its investigational treatment for PD and other central nervous system (CNS) diseases. The list was released during the 35th annual JP Morgan Healthcare Conference, held recently in San Francisco. Genervon…
Vitamin B3 (niacin) was found to boost levels of a compound called NAD that generates energy and repairs DNA, according to new research that suggests boosting Vitamin B3 could keep Parkinson’s disease (PD) at bay. Miguel’ Martin’s team, from left: Juan, Susann, Callum, Miguel, Samantha Credit:…
Get regular updates to your inbox.